Thursday March 1, 2018

  •  
  • Thursday AM

  • 08.15 - 08.30
  • Welcome and introduction

    Frédéric Lioté and Alexander So

  • chairpersons

    Hervé Kempf / Jessica Bertrand

  • 08.30 - 09.00
  • Zebrafish model of pathological calcification

    Leonor Cancela, Faro, Portugal

  • 09.00 - 09.30
  • Wnt, crystals and OA

    Jessica Bertrand, Magdeburg, Germany

  • 09.30 - 10.00
  • Calcification propensity and disease in man

    Andreas Pasch, Bern, Switzerland

  • 10.00 - 10.30
  • COFFEE BREAK

  • chairperson

    Korng Ea / Alexander So

  • 10.30 - 11.00
  • Pyrophosphate and kidney stones: role of ABCC6

    Emmanuel Letavernier, Paris, France

  • 11.00 - 11.30
  • NOVEL DUAL-ENERGY AND MULTI-ENERGY/SPECTRAL CT IMAGING TECHNIQUES OF CALCIUM CRYSTAL DEPOSITION

    Fabio Becce, Lausanne, Switzerland

  • 11.30 - 12.00
  • UNMET NEEDS IN CPPD

    Bob Terkeltaub, San Diego, USA

  • 12.00 - 13.00
  • ABSTRACT PRESENTATIONS

    Use of proton pump inhibitors increases the risk of calcium pyrophosphate deposition (CPPD) in a population-based study

    Tuhina Neogi, San Diego, USA

    Ossifying environment accompanies brain capillary calcification in the mouse model of primary familial brain calcification

    Yvette Zarb, Zurich, Switzerland

    2,8 dihydroxyadenine nephropathy: a granulomatous disease

    Elise Bouderlique, Paris, France

    DNA methylation of SOCS3 as a possible mechanism for persistent urate induced inflammation

    Viola Klück, Nijmegen, The Netherlands

  • 13.00 - 14.00
  • LUNCH

  •  
  • Thursday PM

  • chairpersons

    Korng Ea / Nathalie Busso

  • 14.00 - 14.30
  • Metabolic influences on immune function and relevance to disease

    Leo Joosten, Nijmegen, The Netherland

  • 14.30 - 15.00
  • Metabolomics of hyperuricemia and gout

    Hui-Yong Yin, Shanghai, China

  • 15.00 - 15.30
  • Microbiota and inflammation

    Alexander Haslberger, Vienna, Austria

  • 15.30 - 16.00
  • COFFEE BREAK

  • chairpersons

    Leo Joosten / Frédéric Lioté

  • 16.00 - 16.30
  • NEW INSIGHTS INTO INFLAMMASOME REGULATION

    Fabio Martinon, Lausanne, Switzerland

  • 16.30 - 17.00
  • Microcrystals and NET formation

    Martin Hermann, Erlangen, Germany

  • 17.00 - 17.30
  • ORAL NLRP3 INHIBITORS FOR A WIDE-SPECTRUM OF IL-1BETA MEDIATED DISEASES

    Charles Dinarello, Nijmegen, The Netherland

  • 17.30 - 17.45
  • Prize ceremony of best abstract

    Generation and validation of the first complete knockout model of abcc6a in zebrafish

    M. Van Gils, Ghent, Belgium

  • 17.45 - 18.30
  • EUROGOUT update

    Tony Merriman, Dunedin, New Zealand

  • 19.45
  • SPEAKERS DINNER

  • Friday March 2, 2018

  •  
  • Friday AM

  • chairpersons

    Alexander So / Tony Merriman

  • 08.30 - 09.00
  • UPDATE ON GENETIC STUDIES OF SERUM URATE

    Anna Köttgen, Freiburg, Germany

  • 09.00 - 09.30
  • Gout genetics - future directions

    Tony Merriman, Dunedin, New Zealand

  • 09.30 - 10.00
  • Genetics of hyperuricemia and gout in China

    Yongyong Shi, Quingdao, China

  • 10.00 - 10.30
  • COFFEE BREAK

  • chairpersons

    Hyon Choi / Mike Doherty

  • 10.30 - 11.00
  • Is uric acid linked to osteoarthritis?

    Michael Pillinger, New York, USA

  • 11.00 - 11.30
  • Hyperuricemia and risk of Chronic Kidney Disease

    Austin Stack, Limerick, Ireland

  • 11.30 - 12.00
  • THE GOUT KIDNEY

    Thomas Bardin, Paris, France

  • 12.00 - 13.00
  • ABSTRACT PRESENTATIONS

    Serum urate and incident dementia : a population based study

    Dehlin Mats, Gothenburg, Sweden

    Ultrasound evaluation in follow-up of urate-lowering therapy in gout : the useful study

    Sébastien Ottaviani, Paris, France

    Prevalence and morphology of chronic uric acid nephropathy in 81,200 diagnostic kidney biopsies and a novel mouse model

    Stefanie Steiger, Munich, Germany

    Exon sequencing of SLC22A11 (OAT4) and SLC22A12 (URAT1) in hyperuricaemic individuals;genetic evidence of a role for OAT4 in urate secretion

    Tanya J Major, Auckland, New Zealand

  • 13.00 - 14.00
  • LUNCH

  •  
  • Friday PM

  • chairpersons

    Fred Lioté / Korng Ea

  • 14.00 - 14.30
  • Undergraduate medical education of gout and other crystal-related arthropathies

    Abhsishek Abhishek, Nottingham, UK

  • 14.30 - 15.00
  • Long term results of gout nurse-led management in the UK

    Michael Doherty, Nottingham, United Kingdom

  • 15.00 - 15.30
  • Therapeutic education in gout

    Aline Frazier, Paris, France

  • 15.30 - 16.00
  • COFFEE BREAK

  • chairpersons

    Bob Terkeltaub / Alexander So

  • 16.00 - 16.30
  • GOUT DRUG SAFETY - PHARMACOGENETICS OF HLA-B*5801 & UPDATES

    Hyon Choi, Boston, USA

  • 16.30 - 17.30
  • CRITICAL UPDATE ON THE CURRENT AND FUTURE URICOSURICS

    Fernando Perez-Ruiz, Bilbao, Spain

  • 17.30 - 18.00
  • CONCLUDING REMARKS AND DEPARTURE